[
    [
        {
            "time": "2018-08-12",
            "original_text": "【申万宏源医药闫天一】20180812 周观点：企稳，市场情绪自我修复",
            "features": {
                "keywords": [
                    "申万宏源",
                    "医药",
                    "企稳",
                    "市场情绪",
                    "自我修复"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "【申万宏源医药闫天一】20180812 周观点：企稳，市场情绪自我修复",
                "Correlation": 6,
                "Sentiment": 6,
                "Importance": 5,
                "Impact": 5,
                "Duration": 6,
                "Entity_Density": 3,
                "Market_Scope": 7,
                "Time_Proximity": 4,
                "Headline_Structure": 7,
                "Source_Recency": 3
            }
        },
        {
            "time": "2018-08-12",
            "original_text": "恒瑞医药：公司产品拟纳入优先审评程序",
            "features": {
                "keywords": [
                    "恒瑞医药",
                    "优先审评",
                    "产品"
                ],
                "sentiment_score": 0.9,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "恒瑞医药：公司产品拟纳入优先审评程序",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 6,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "2018-08-12",
            "original_text": "医疗保健：创新药进入兑现期 荐8股",
            "features": {
                "keywords": [
                    "医疗保健",
                    "创新药",
                    "兑现期"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "医疗保健"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "医疗保健：创新药进入兑现期 荐8股",
                "Correlation": 5,
                "Sentiment": 7,
                "Importance": 6,
                "Impact": 5,
                "Duration": 6,
                "Entity_Density": 4,
                "Market_Scope": 8,
                "Time_Proximity": 5,
                "Headline_Structure": 7,
                "Source_Recency": 5
            }
        },
        {
            "time": "2018-08-12",
            "original_text": "[买入-A评级] 恒瑞医药(600276)中报点评：中报业绩稳健增长 多款重磅新药进入收获期",
            "features": {
                "keywords": [
                    "买入",
                    "A评级",
                    "恒瑞医药",
                    "中报",
                    "业绩稳健增长",
                    "重磅新药",
                    "收获期"
                ],
                "sentiment_score": 0.95,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "[买入-A评级] 恒瑞医药(600276)中报点评：中报业绩稳健增长 多款重磅新药进入收获期",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 9,
                "Duration": 8,
                "Entity_Density": 10,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        }
    ]
]